Detalhe da pesquisa
1.
Population Effectiveness of Dolutegravir Implementation in Uganda - A Prospective Observational Cohort Study (DISCO): 48-week Results.
J Infect Dis
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38748986
2.
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).
Clin Infect Dis
; 76(3): e526-e529, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737946
3.
Geographic variation in 5-year mortality following HIV diagnosis: implications for clinical interventions.
AIDS Care
; 35(12): 2016-2023, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36942651
4.
Hair salons and stylist-client social relationships as facilitators of community-based contraceptive uptake in KwaZulu-Natal, South Africa: a qualitative analysis.
Reprod Health
; 18(1): 178, 2021 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461925
5.
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
N Engl J Med
; 387(3): 275-277, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767428
6.
Short-course neoadjuvant in situ vaccination for murine melanoma.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039460
7.
Uptake of community- versus clinic-based antiretroviral therapy dispensing in the Central Chronic Medication Dispensing and Distribution program in South Africa.
J Int AIDS Soc
; 25(1): e25877, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35077611
8.
Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618290
9.
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant.
JCI Insight
; 7(19)2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214224
10.
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection.
medRxiv
; 2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262089
11.
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses.
medRxiv
; 2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262094
12.
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.
J Immunother Cancer
; 7(1): 344, 2019 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31810498